Celldex to Present at Two Upcoming Investor Conferences
The live webcasts of the presentations will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. Replays of the presentations will be available following each event.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit http://www.celldextherapeutics.com.
Sarah CavanaughVice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc.(781) 433-3161 email@example.com
News Provided by Acquire Media